Volume 23, Issue 6 pp. 582-589
Research Article
Full Access

Branchio-oto-renal syndrome: The mutation spectrum in EYA1 and its phenotypic consequences

Eugene H. Chang

Eugene H. Chang

Molecular Otolaryngology Research Labs, University of Iowa, Iowa City, Iowa

Search for more papers by this author
Maithilee Menezes

Maithilee Menezes

Molecular Otolaryngology Research Labs, University of Iowa, Iowa City, Iowa

Search for more papers by this author
Nicole C. Meyer

Nicole C. Meyer

Molecular Otolaryngology Research Labs, University of Iowa, Iowa City, Iowa

Search for more papers by this author
Robert A. Cucci

Robert A. Cucci

Molecular Otolaryngology Research Labs, University of Iowa, Iowa City, Iowa

Search for more papers by this author
Virginie S. Vervoort

Virginie S. Vervoort

Department of Genetics and Biochemistry, Clemson University, Clemson, South Carolina

Greenwood Genetic Center, Greenwood, South Carolina

Search for more papers by this author
Charles E. Schwartz

Charles E. Schwartz

Department of Genetics and Biochemistry, Clemson University, Clemson, South Carolina

Greenwood Genetic Center, Greenwood, South Carolina

Search for more papers by this author
Richard J.H. Smith

Corresponding Author

Richard J.H. Smith

Molecular Otolaryngology Research Labs, University of Iowa, Iowa City, Iowa

Sterba Hearing Research Professor and Vice-Chair, Director, Molecular Otolaryngology Research Laboratories, Department of Otolaryngology, 200 Hawkins Drive, University of Iowa, Iowa City, IA 52242Search for more papers by this author
First published: 30 April 2004
Citations: 185

Communicated by Mark H. Paalman

The supplementary material referred to in this article can be viewed at www.interscience.wiley.com/jpages/1059-7794/suppmat

Abstract

EYA1 mutations cause branchio-oto-renal (BOR) syndrome. These mutations include single nucleotide transitions and transversions, small duplications and deletions, and complex genomic rearrangements. The last cannot be detected by coding sequence analysis of EYA1. We sought to refine the clinical diagnosis of BOR syndrome by analyzing phenotypic data from families segregating EYA1 disease-causing mutations. Based on genotype–phenotype analyses, we propose new criteria for the clinical diagnosis of BOR syndrome. We found that in approximately 40% of persons meeting our criteria, EYA1 mutations were identified. Of these mutations, 80% were coding sequence variants identified by SSCP, and 20% were complex genomic rearrangements identified by a semiquantitative PCR-based screen. We conclude that genetic testing of EYA1 should include analysis of the coding sequence and a screen for complex rearrangements. Hum Mutat 23:582–589, 2004. © 2004 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.